ZURA — Zura Bio Ltd catalysts
Next verified catalyst
2026-11-01 — Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 4mo
ESTIMATED |
READOUT
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Phase 2 · Hidradenitis Suppurativa (HS) |
ZURA Zura Bio Ltd | Tibulizumab Dose A, Tibulizumab Dose B |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|